| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.5 | 0.0003 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.25 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.22 | 0.3 |